IFOSFAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Ifosfamide patents expire, and what generic alternatives are available?
Ifosfamide is a drug marketed by Fresenius Kabi Usa, Hikma, Meitheal, Mylan Labs Ltd, and Teva Pharms Usa. and is included in six NDAs.
The generic ingredient in IFOSFAMIDE is ifosfamide; mesna. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ifosfamide; mesna profile page.
Summary for IFOSFAMIDE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 130 |
Clinical Trials: | 453 |
Patent Applications: | 5,110 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for IFOSFAMIDE |
What excipients (inactive ingredients) are in IFOSFAMIDE? | IFOSFAMIDE excipients list |
DailyMed Link: | IFOSFAMIDE at DailyMed |
Recent Clinical Trials for IFOSFAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Washington University School of Medicine | Phase 1/Phase 2 |
Polaris Group | Phase 1/Phase 2 |
David Bond, MD | Phase 2 |
Pharmacology for IFOSFAMIDE
Drug Class | Alkylating Drug |
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for IFOSFAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for IFOSFAMIDE
US Patents and Regulatory Information for IFOSFAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 076078-001 | May 28, 2002 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Meitheal | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 076657-001 | Apr 4, 2007 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fresenius Kabi Usa | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 090181-002 | Sep 22, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | IFOSFAMIDE/MESNA KIT | ifosfamide; mesna | INJECTABLE;INTRAVENOUS | 075874-002 | Feb 26, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Meitheal | IFOSFAMIDE | ifosfamide | INJECTABLE;INJECTION | 076657-002 | Apr 4, 2007 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |